Financials
- Market Capitalization 579.94 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2641 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 5.50 USD | -1.43% | +0.73% | +24.15% | +250.32% | 768.15 M USD | ||
| 2697 | CSTL Castle Biosciences, Inc. - Common stock | 22.98 USD | -3.12% | -5.67% | +9.12% | -6.64% | 696.98 M USD | ||
| 2855 | MYGN Myriad Genetics, Inc. - Common Stock | 5.86 USD | +0.51% | -3.78% | +26.57% | -29.14% | 553.47 M USD | ||
| 3242 | LAB Standard BioTools Inc. - Common Stock | 0.85 USD | -7.61% | -3.41% | -5.56% | -32.00% | 331.56 M USD |
Frequently asked questions about Fulgent Genetics, Inc. - Common Stock
What is the Fulgent Genetics, Inc. - Common Stock stock price today?
The current price of Fulgent Genetics, Inc. - Common Stock (FLGT) is 20.42. Over the past 24 hours, the stock has changed by -0.63%. Follow the FLGT chart for real-time price dynamics.
What is the stock ticker of Fulgent Genetics, Inc. - Common Stock?
Fulgent Genetics, Inc. - Common Stock trades under the ticker FLGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Fulgent Genetics, Inc. - Common Stock stock going up?
FLGT has changed by -4.98% over the last week, +9.31% over the last month, and -13.58% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Fulgent Genetics, Inc. - Common Stock net income for the last quarter?
Fulgent Genetics, Inc. - Common Stock reported net income of -24.83 M for the last quarter. The previous quarter showed -23.42 M, which means net income changed by -6.01%.
How many employees does Fulgent Genetics, Inc. - Common Stock have?
As of the latest available data, Fulgent Genetics, Inc. - Common Stock has 1 315 employees. Workforce size can provide additional context about the company's scale and operations.
What is Fulgent Genetics, Inc. - Common Stock EBITDA?
Fulgent Genetics, Inc. - Common Stock EBITDA is -28.62 M, and its EBITDA margin is -40.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Fulgent Genetics, Inc. - Common Stock stock?
You can buy Fulgent Genetics, Inc. - Common Stock (FLGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Fulgent Genetics, Inc. - Common Stock stock?
Investing in Fulgent Genetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FLGT chart and related analysis on metatrader.com as part of your research.